34 results
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Dificile Risk by Antibiotic ... CDifficile #Infection #Antibiotics ... #Association #Pharmacology ... #Clostridium #Table ... #Comparison #OddsRatio
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Antibiogram - Antibiotic ... Resistance Table ... #Antibiogram #Antibiotic ... InfectiousDiseases #Resistant #Comparison ... #Table #Pharmacology
Clinical Presentation and Diagnosis of Common Causes of Vaginitis

#Vaginitis #Differential #Diagnosis #Comparison #Table #Testing #Gynecology #OBGyn
Clinical Presentation ... Differential #Diagnosis #Comparison ... #Table #Testing
Angiotensin Receptor Blocker (ARB) Antihypertensive Dose Comparison

#Pharmacology #Angiotensin #Receptor #Blocker #ARB #Conversion #Table #Dose #Dosages

** GrepMed
Antihypertensive Dose Comparison ... #Pharmacology ... ARB #Conversion #Table ... Recommended Text: Clinical ... Pharmacology Made
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Recommendations for Treating ... chew, or crush tablet ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Preventing and Treating ... Treating Acute Infection ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Preventing and Treating ... Preferred Therapy for Treating ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Recommendations for Treating ... every 21 days Treating ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
HIV-AIDS Preventing Clinical ... and preventing clinical ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
3 years • Co-testing ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology